Assessing the Time Demands of Cancer
Running, not enrolling
Conditions studied: Metastatic Breast Cancer, Ovarian Cancer
In brief
A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion services active; confirm and correct (if needed) smartphone-detected activities and trips; use the app interface to provide additional information on activities and trips related to cancer treatment tasks; complete daily surveys regarding well-being; and at the end of the 28 day period, complete an online survey.
Key facts
- Study ID
- NCT05708703
- Run by
- Masonic Cancer Center, University of Minnesota
- People needed
- 78
- Starts
- 2023-11-13
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2025-09-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age or older
- Diagnosed with advanced stage (III, IV) ovarian (ovarian, fallopian tube or primary peritoneal) or metastatic breast cancer [do not need to be newly diagnosed]
- Currently receiving any type of therapy for their cancer [can be front-line, maintenance therapy, or treatment for recurrence]
- Able to complete study tasks in English
- Able to provide voluntary informed consent
- Own an Android or iOS smartphone on which the operating system is version 9.0 or higher for Android or 10.0 higher for iOS; or willing to use a researcher-provided smartphone
You may not qualify if…
- Those who are currently incarcerated
- Have opted out of research contact
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- Masonic Cancer Center - University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.